SI1641803T1 - Tienopirimidinski derivati kot inhibitorji kalijevih kanalov - Google Patents

Tienopirimidinski derivati kot inhibitorji kalijevih kanalov

Info

Publication number
SI1641803T1
SI1641803T1 SI200431150T SI200431150T SI1641803T1 SI 1641803 T1 SI1641803 T1 SI 1641803T1 SI 200431150 T SI200431150 T SI 200431150T SI 200431150 T SI200431150 T SI 200431150T SI 1641803 T1 SI1641803 T1 SI 1641803T1
Authority
SI
Slovenia
Prior art keywords
potassium channel
channel inhibitors
thienopyrimidine derivatives
thienopyrimidine
derivatives
Prior art date
Application number
SI200431150T
Other languages
English (en)
Inventor
John Ford
Nicholas John Palmer
John Frederick Atherall
David John Madge
Brad Sherborne
Mark Bushfield
Edward Benedict Stevens
Original Assignee
Xention Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0315950.6A external-priority patent/GB0315950D0/en
Application filed by Xention Ltd filed Critical Xention Ltd
Publication of SI1641803T1 publication Critical patent/SI1641803T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
SI200431150T 2003-06-11 2004-06-10 Tienopirimidinski derivati kot inhibitorji kalijevih kanalov SI1641803T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47751803P 2003-06-11 2003-06-11
GBGB0315950.6A GB0315950D0 (en) 2003-06-11 2003-06-11 Compounds
PCT/GB2004/002454 WO2004111057A1 (en) 2003-06-11 2004-06-10 Thienopyrimidine derivatives as potassium channel inhibitors
EP04736524A EP1641803B3 (en) 2003-06-11 2004-06-10 Thienopyrimidine derivatives as potassium channel inhibitors

Publications (1)

Publication Number Publication Date
SI1641803T1 true SI1641803T1 (sl) 2009-08-31

Family

ID=33554173

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431150T SI1641803T1 (sl) 2003-06-11 2004-06-10 Tienopirimidinski derivati kot inhibitorji kalijevih kanalov

Country Status (16)

Country Link
EP (1) EP1641803B3 (sl)
KR (1) KR101186678B1 (sl)
CN (1) CN1823071B (sl)
AT (1) ATE425982T1 (sl)
AU (1) AU2004247470B2 (sl)
BR (1) BRPI0411239A (sl)
CA (1) CA2528848C (sl)
DE (1) DE602004020070D1 (sl)
DK (1) DK1641803T3 (sl)
ES (1) ES2324536T7 (sl)
HK (1) HK1093064A1 (sl)
MX (1) MXPA05013549A (sl)
PL (1) PL1641803T6 (sl)
SI (1) SI1641803T1 (sl)
WO (1) WO2004111057A1 (sl)
ZA (1) ZA200600225B (sl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
JP2008505084A (ja) * 2004-06-29 2008-02-21 アムゲン インコーポレイティッド フラノピリミジン
BRPI0516242B1 (pt) * 2004-10-21 2014-10-07 Dow Agrosciences Llc Compostos tieno-pirimidina com atividade fungicida, bem como composição fungicida e método para o controle ou prevenção de ataque fúngico
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
US7576080B2 (en) * 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
WO2007030582A2 (en) * 2005-09-09 2007-03-15 Bristol-Myers Squibb Company Acyclic ikur inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
DE102007027800A1 (de) * 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
WO2010048287A2 (en) 2008-10-22 2010-04-29 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Radioprotective agents
ES2665277T3 (es) 2009-03-13 2018-04-25 Katholieke Universiteit Leuven K.U. Leuven R&D Análogos de purina y su uso como agentes inmunosupresores
CA2772642C (en) 2009-09-03 2017-08-29 Bristol-Myers Squibb Company Quinazolines as potassium ion channel inhibitors
EP3533797B1 (en) * 2010-02-17 2023-12-20 Takeda Pharmaceutical Company Limited Heterocyclic compound
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (sl) 2011-07-01 2018-04-28
WO2013072693A1 (en) * 2011-11-15 2013-05-23 Xention Limited Thieno [2, 3 - c] pyrazoles for use as potassium channel inhibitors
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
AU2012340869B2 (en) 2011-11-23 2017-03-02 Cancer Research Technology Limited Thienopyrimidine inhibitors of atypical protein kinase C
EP2806865A1 (en) 2012-01-27 2014-12-03 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases
KR20150128768A (ko) * 2013-03-07 2015-11-18 글락소스미스클라인 엘엘씨 시르투인 조절제로서의 티에노[3,2-d]피리미딘-6-카르복스아미드 및 유사체
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248593A1 (de) * 1985-01-11 1987-08-12 Univ Halle Wittenberg Verfahren zur herstellung von 4-basischsubstituierten thieno/2,3-d/pyrimidin-6-ylcarbonsaeureestern
AU781365B2 (en) * 1999-12-21 2005-05-19 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors

Also Published As

Publication number Publication date
ES2324536T3 (es) 2009-08-10
DK1641803T3 (da) 2009-06-29
AU2004247470B2 (en) 2009-04-23
BRPI0411239A (pt) 2006-07-18
WO2004111057A1 (en) 2004-12-23
CN1823071B (zh) 2012-12-19
ES2324536T7 (es) 2012-03-16
HK1093064A1 (en) 2007-02-23
ZA200600225B (en) 2007-04-25
EP1641803A1 (en) 2006-04-05
ATE425982T1 (de) 2009-04-15
CA2528848C (en) 2012-09-04
CN1823071A (zh) 2006-08-23
EP1641803B1 (en) 2009-03-18
PL1641803T3 (pl) 2009-08-31
AU2004247470A1 (en) 2004-12-23
CA2528848A1 (en) 2004-12-23
EP1641803B3 (en) 2010-12-08
KR20060057539A (ko) 2006-05-26
KR101186678B1 (ko) 2012-09-27
MXPA05013549A (es) 2006-04-05
PL1641803T6 (pl) 2011-04-29
DE602004020070D1 (de) 2010-10-07

Similar Documents

Publication Publication Date Title
HK1093064A1 (en) Thienopyrimidine derivatives as potassium channel inhibitors
IL260127B (en) mek inhibitors and methods of using them
SG164368A1 (en) Treatment of cancer
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
GB2430935A (en) Tetrapeptide analogs
TW200740803A (en) Heterocyclic derivatives as modulators of ion channels
MY161991A (en) Proteasome inhibitors
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
CA2603830A1 (en) PYRIDINE [2,3-B] PYRAZINONES
WO2006050476A3 (en) Pyrimidine derivatives as ion channel modulators and methods of use
SE0301700D0 (sv) Novel compounds
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
ZA200710332B (en) Bicyclic derivatives as modulators of ion channels
MXPA05014166A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
EP1551388A4 (en) COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME
JO3046B1 (ar) اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.
TW200714284A (en) Novel method
UA96742C2 (en) Mek inhibitors and use thereof
ZA200605653B (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
MY180594A (en) Proteasome inhibitors